Interactions between folate and aging for carcinogenesis
-
Sang-Woon Choi
und Simonetta Friso
Abstract
Inadequate folate intake and aging are each strongly implicated as important risk factors for certain cancers. Since both folate depletion and aging are strongly associated with hyperhomocysteinemia, genomic DNA hypomethylation, and increased uracil misincorporation into DNA, it appears that each of them enhances carcinogenesis by inducing a derangement of one-carbon metabolism that supplies one-carbons to biological methylation reactions and nucleotide synthesis. Recent studies have demonstrated that inadequate dietary folate and aging may interact and synergistically disturb the normal homeostasis of one-carbon metabolism, thereby provoking subsequent biochemical and molecular aberrations, including alterations in critical gene expression related to carcinogenesis. These studies have further indicated that modest folate supplementation may reverse or partially ameliorate those adverse effects induced by folate depletion and aging.
References
1. Benito E, Stiggelbout A, Bosch FX, Obrador A, Kaldor J, Mulet M, et al. Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer 1991; 49:161–7.10.1002/ijc.2910490202Suche in Google Scholar
2. Benito E, Cabeza E, Moreno V, Obrador A, Bosch FX. Diet and colorectal adenomas: a case-control study in Majorca. Int J Cancer 1993; 55:213–9.10.1002/ijc.2910550208Suche in Google Scholar
3. Freudenheim JL, Graham S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991; 20:368–74.10.1093/ije/20.2.368Suche in Google Scholar
4. Paspatis GA, Kalafatis E, Oros L, Xourgias V, Koutsioumpa P, Karamanolis DG. Folate status and adenomatous colonic polyps. A colonoscopically controlled study. Dis Colon Rectum 1995; 38:64–7.10.1007/BF02053860Suche in Google Scholar
5. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995; 87:265–73.10.1093/jnci/87.4.265Suche in Google Scholar
6. Giovannucci E, Stampfer MJ, Colditz GA, Rimm EB, Trichopoulos D, Rosner BA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993; 85:875–84.10.1093/jnci/85.11.875Suche in Google Scholar
7. Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology 1989; 97:255–9.10.1016/0016-5085(89)90058-9Suche in Google Scholar
8. Lashner BA. Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 1993; 119:549–54.10.1007/BF01686465Suche in Google Scholar PubMed
9. Cravo ML, Mason JB, Dayal Y, Hutchinson M, Smith D, Selhub J, et al. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res 1992; 52:5002–6.Suche in Google Scholar
10. Kim YI, Salomon RN, Graeme-Cook F, Choi SW, Smith DE, Dallal GE, et al. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 1996; 39:732–40.10.1136/gut.39.5.732Suche in Google Scholar PubMed PubMed Central
11. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000; 130:129–32.10.1093/jn/130.2.129Suche in Google Scholar PubMed
12. Friso S, Choi SW. Gene-nutrient interactions and DNA methylation. J Nutr 2002; 132(Suppl):2382S–7S.10.1093/jn/132.8.2382SSuche in Google Scholar
13. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002; 132(Suppl):2413S–8S.10.1093/jn/132.8.2413SSuche in Google Scholar
14. Choi SW, Friso S, Keyes MK, Mason JB. Folate supplementation increases genomic DNA methylation in the liver of elder rats. Br J Nutr 2005; 93:31–5.10.1079/BJN20041283Suche in Google Scholar
15. Choi SW, Friso S, Dolnikowski GG, Bagley PJ, Edmondson AN, Smith DE, et al. Biochemical and molecular aberrations in the rat colon due to folate depletion are age-specific. J Nutr 2003; 133:1206–12.10.1093/jn/133.4.1206Suche in Google Scholar
16. Crott JW, Choi SW, Ordovas JM, Ditelberg JS, Mason JB. Effects of dietary folate and aging on gene expression in the colonic mucosa of rats: implications for carcinogenesis. Carcinogenesis 2004; 25:69–76.10.1093/carcin/bgg150Suche in Google Scholar
17. Ghandour H, Lin BF, Choi SW, Mason JB, Selhub J. Folate status and age affect the accumulation of L-isoaspartyl residues in rat liver proteins. J Nutr 2002; 132:1357–60.10.1093/jn/132.6.1357Suche in Google Scholar
18. Crott JW, Choi SW, Branda RF, Mason JB. Accumulation of mitochondrial DNA deletions is age, tissue and folate-dependent in rats. Mutat Res 2005; 570:63–70.10.1016/j.mrfmmm.2004.09.009Suche in Google Scholar
19. MacKenzie RE. Biogenesis and interconversion of substituted tetrahydrofolates. In: Blakley RL, Benkovic SJ, editors. Folate and pterins, vol 1. New York: Wiley, 1984:255–306.Suche in Google Scholar
20. Shane B. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. Vitam Horm 1989; 45:263–335.10.1016/S0083-6729(08)60397-0Suche in Google Scholar
21. Weissbach H, Taylor RT. Roles of vitamin B 12 and folic acid in methionine synthesis. Vitam Horm 1970; 28:415–40.10.1016/S0083-6729(08)60905-XSuche in Google Scholar
22. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000; 275:29318–23.10.1074/jbc.M002725200Suche in Google Scholar PubMed
23. Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G. Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 2000; 26:243–54.10.1055/s-2000-8469Suche in Google Scholar PubMed
24. Craig SA. Betaine in human nutrition. Am J Clin Nutr 2004; 80:539–49.10.1093/ajcn/80.3.539Suche in Google Scholar PubMed
25. Verhoef P, Steenge GR, Boelsma E, van Vliet T, Olthof MR, Katan MB. Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans. Am J Clin Nutr 2004; 80:674–9.10.1093/ajcn/80.3.674Suche in Google Scholar PubMed
26. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J. Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem J 1994; 298:415–9.10.1042/bj2980415Suche in Google Scholar PubMed PubMed Central
27. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 1998; 128:1204–12.10.1093/jn/128.7.1204Suche in Google Scholar PubMed
28. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr 2000; 72:998–1003.10.1093/ajcn/72.4.998Suche in Google Scholar PubMed
29. Balaghi M, Horne DW, Wagner C. Hepatic one-carbon metabolism in early folate deficiency in rats. Biochem J 1993; 291:145–9.10.1042/bj2910145Suche in Google Scholar PubMed PubMed Central
30. Kim YI, Christmas JK, Fleet JC, Cravo ML, Salomon RN, Smith D, et al. Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am J Clin Nutr 1995; 61:1083–90.10.1093/ajcn/61.5.1083Suche in Google Scholar
31. Sohn KJ, Stempak JM, Reid S, Shirwadkar S, Mason JB, Kim YI. The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis 2003; 24:81–90.10.1093/carcin/24.1.81Suche in Google Scholar PubMed
32. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000; 71:121–38.10.1006/mgme.2000.3027Suche in Google Scholar PubMed
33. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 1999; 10:66–88.10.1016/S0955-2863(98)00074-6Suche in Google Scholar
34. Blount BC, Ames BN. Analysis of uracil in DNA by gas chromatography-mass spectrometry. Anal Biochem 1994; 219:195–200.10.1006/abio.1994.1257Suche in Google Scholar
35. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997; 94:3290–5.10.1073/pnas.94.7.3290Suche in Google Scholar
36. Fenech M, Aitken C, Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 1998; 19:1163–71.10.1093/carcin/19.7.1163Suche in Google Scholar
37. Schneede J, Refsum H, Ueland PM. Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost 2000; 26:263–79.10.1055/s-2000-8471Suche in Google Scholar
38. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 1993; 270:2693–8.10.1001/jama.1993.03510220049033Suche in Google Scholar
39. Hernanz A, Fernandez-Vivancos E, Montiel C, Vazquez JJ, Arnalich F. Changes in the intracellular homocysteine and glutathione content associated with aging. Life Sci 2000; 67:1317–24.10.1016/S0024-3205(00)00722-0Suche in Google Scholar
40. Ingenbleek , Y, Young VR. The essentiality of sulfur is closely related to nitrogen metabolism: a clue to hyper-homocysteinemia. Nutr Res Rev 2004; 17:135–51.10.1079/NRR200489Suche in Google Scholar
41. Ingenbleek Y, Hardillier E, Jung L. Subclinical protein malnutrition is a determinant of hyperhomocysteinemia. Nutrition 2002; 18:40–6.10.1016/S0899-9007(01)00783-3Suche in Google Scholar
42. Costello JF, Plass C. Methylation matters. J Med Genet 2001; 38:285–303.10.1136/jmg.38.5.285Suche in Google Scholar PubMed PubMed Central
43. Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis 2000; 21:461–7.10.1093/carcin/21.3.461Suche in Google Scholar
44. Liu L, Wylie RC, Andrews LG, Tollefsbol TO. Aging, cancer and nutrition: the DNA methylation connection. Mech Ageing Dev 2003; 124:989–98.10.1016/j.mad.2003.08.001Suche in Google Scholar
45. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985; 228:187–90.10.1126/science.2579435Suche in Google Scholar
46. Holliday R. The inheritance of epigenetic defects. Science 1987; 238:163–70.10.1126/science.3310230Suche in Google Scholar
47. Vanyushin BF, Mazin AL, Vasilyev VK, Belozersky AN. The content of 5-methylcytosine in animal DNA: the species and tissue specificity. Biochim Biophys Acta 1973; 299:397–403.10.1016/0005-2787(73)90264-5Suche in Google Scholar
48. Richardson B. Impact of aging on DNA methylation. Ageing Res Rev 2003; 2:245–61.10.1016/S1568-1637(03)00010-2Suche in Google Scholar
49. Slagboom PE, de Leeuw WJ, Vijg J. Messenger RNA levels and methylation patterns of GAPDH and beta-actin genes in rat liver, spleen and brain in relation to aging. Mech Ageing Dev 1990; 53:243–57.10.1016/0047-6374(90)90042-ESuche in Google Scholar
50. Ono T, Uehara Y, Kurishita A, Tawa R, Sakurai H. Biological significance of DNA methylation in the ageing process. Age Ageing 1993; 22:S34–43.10.1093/ageing/22.suppl_1.S34Suche in Google Scholar
51. Issa JP. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 2000; 249:101–18.10.1007/978-3-642-59696-4_7Suche in Google Scholar PubMed
52. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7:536–40.10.1038/ng0894-536Suche in Google Scholar PubMed
53. Bailey LB. Folate status assessment. J Nutr 1990; 120(Suppl 11):1508–11.10.1093/jn/120.suppl_11.1508Suche in Google Scholar
54. Baker H, Jaslow SP, Frank O. Severe impairment of dietary folate utilization in the elderly. J Am Geriatr Soc 1978; 26:218–21.10.1111/j.1532-5415.1978.tb01962.xSuche in Google Scholar
55. Webster SG, Leeming JT. Erythrocyte folate levels in young and old. J Am Geriatr Soc 1979; 27:451–4.10.1111/j.1532-5415.1979.tb01725.xSuche in Google Scholar
56. Russell RM, Krasinski SD, Samloff IM, Jacob RA, Hartz SC, Brovender SR. Folic acid malabsorption in atrophic gastritis. Possible compensation by bacterial folate synthesis. Gastroenterology 1986; 91:1476–82.10.1016/0016-5085(86)90204-0Suche in Google Scholar
57. Garry PJ, Goodwin JS, Hunt WC. Folate and vitamin B12 status in a healthy elderly population. J Am Geriatr Soc 1984; 32:719–26.10.1111/j.1532-5415.1984.tb04170.xSuche in Google Scholar PubMed
58. Hanger HC, Sainsbury R, Gilchrist NL, Beard ME, Duncan JM. A community study of vitamin B12 and folate levels in the elderly. J Am Geriatr Soc 1991; 39:1155–9.10.1111/j.1532-5415.1991.tb03566.xSuche in Google Scholar PubMed
59. Varela-Moreiras G, Selhub J. Long-term folate deficiency alters folate content and distribution differentially in rat tissues. J Nutr 1992; 122:986–91.10.1093/jn/122.4.986Suche in Google Scholar PubMed
60. Varela-Moreiras G, Perez-Olleros L, Garcia-Cuevas M, Ruiz-Roso B. Effects of ageing on folate metabolism in rats fed a long-term folate deficient diet. Int J Vitam Nutr Res 1994; 64:294–9.Suche in Google Scholar
61. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123:1939–51.10.1093/jn/123.11.1939Suche in Google Scholar PubMed
62. Pogribny IP, Muskhelishvili L, Miller BJ, James SJ. Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 1997; 18:2071–6.10.1093/carcin/18.11.2071Suche in Google Scholar PubMed
63. Friso S, Choi SW, Dolnikowski GG, Selhub J. A new method to assess genomic DNA methylation using high performance liquid chromatography-electrospray ionization mass spectrometry. Anal Chem 2002; 74:4526–31.10.1021/ac020050hSuche in Google Scholar PubMed
64. Galletti P, Ingrosso D, Manna C, Clemente G, Zappia V. Protein damage and methylation-mediated repair in the erythrocyte. Biochem J 1995; 306:313–25.10.1042/bj3060313Suche in Google Scholar PubMed PubMed Central
65. Perna AF, Ingrosso D, Satta E, Romano M, Cimmino A, Galletti P, et al. Metabolic consequences of hyper-homocysteinemia in uremia. Am J Kidney Dis 2001; 38(Suppl 1):S85–90.10.1053/ajkd.2001.27411Suche in Google Scholar PubMed
66. Young AL, Carter WG, Doyle HA, Mamula MJ, Aswad DW. Structural integrity of histone H2B in vivo requires the activity of protein L-isoaspartate O-methyltransferase, a putative protein repair enzyme. J Biol Chem 2001; 276:37161–5.10.1074/jbc.M106682200Suche in Google Scholar PubMed
67. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995; 377:646–65.10.1038/377646a0Suche in Google Scholar PubMed
©2005 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Homocysteine research – where do we stand and where are we going?
- Hyperhomocysteinemia and arteriosclerosis: historical perspectives
- Homocysteine and heart failure: a review of investigations from the Framingham Heart Study
- Homocysteine and vascular disease in diabetes: a double hit?
- Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia
- Effects of homocysteine on vascular and tissue adenosine: a stake in homocysteine pathogenicity?
- Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease
- Carotid narrowing degree and plasma thiol levels in carotid endarterectomy patients
- Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy
- Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation
- Hyperhomocysteinemia and macromolecule modifications in uremic patients
- Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients
- Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population
- Homocysteine, folic acid and vitamin B12 in relation to pre- and postnatal health aspects
- Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project
- A laboratory algorithm with homocysteine as the primary parameter reduces the cost of investigation of folate and cobalamin deficiency
- Betaine: a key modulator of one-carbon metabolism and homocysteine status
- Molecular targeting by homocysteine: a mechanism for vascular pathogenesis
- Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro
- Homocysteine in relation to cognitive performance in pathological and non-pathological conditions
- Homocysteine and B vitamins in mild cognitive impairment and dementia
- Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study
- Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions
- Homocysteine – a newly recognised risk factor for osteoporosis
- Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women
- Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
- Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance
- Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status
- Asymmetric dimethylarginine, homocysteine and renal function – is there a relation?
- Interactions between folate and aging for carcinogenesis
- The potential cocarcinogenic effect of vitamin B12 deficiency
- The vegetarian lifestyle and DNA methylation
Artikel in diesem Heft
- Homocysteine research – where do we stand and where are we going?
- Hyperhomocysteinemia and arteriosclerosis: historical perspectives
- Homocysteine and heart failure: a review of investigations from the Framingham Heart Study
- Homocysteine and vascular disease in diabetes: a double hit?
- Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia
- Effects of homocysteine on vascular and tissue adenosine: a stake in homocysteine pathogenicity?
- Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease
- Carotid narrowing degree and plasma thiol levels in carotid endarterectomy patients
- Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy
- Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation
- Hyperhomocysteinemia and macromolecule modifications in uremic patients
- Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients
- Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population
- Homocysteine, folic acid and vitamin B12 in relation to pre- and postnatal health aspects
- Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project
- A laboratory algorithm with homocysteine as the primary parameter reduces the cost of investigation of folate and cobalamin deficiency
- Betaine: a key modulator of one-carbon metabolism and homocysteine status
- Molecular targeting by homocysteine: a mechanism for vascular pathogenesis
- Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro
- Homocysteine in relation to cognitive performance in pathological and non-pathological conditions
- Homocysteine and B vitamins in mild cognitive impairment and dementia
- Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study
- Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions
- Homocysteine – a newly recognised risk factor for osteoporosis
- Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women
- Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
- Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance
- Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status
- Asymmetric dimethylarginine, homocysteine and renal function – is there a relation?
- Interactions between folate and aging for carcinogenesis
- The potential cocarcinogenic effect of vitamin B12 deficiency
- The vegetarian lifestyle and DNA methylation